Biodesix Cash Flow from Operating Activities 2020-2024 | BDSX
Biodesix cash flow from operating activities from 2020 to 2024. Cash flow from operating activities can be defined as a company's cash flows from operations.
| Biodesix Annual Cash Flow Ops (Millions of US $) |
|
|---|---|
| 2023 | $-23 |
| 2022 | $-45 |
| 2021 | $-28 |
| 2020 | $-21 |
| 2019 | $-22 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.164B | $0.049B |
| Biodesix Inc. is a data-driven diagnostic solutions company. It offers blood-based tests across the lung cancer continuum of care. The company also offers include diagnostic research, clinical research, development, and testing services to biopharmaceutical companies, as well as develops and commercializes companion diagnostics. Biodesix Inc. is based in Boulder, Colorado. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $125.152B | 15.70 |
| Cencora (COR) | United States | $45.190B | 17.62 |
| ICON (ICLR) | Ireland | $26.796B | 25.30 |
| DiDi Global (DIDIY) | China | $22.261B | 0.00 |
| Avantor (AVTR) | United States | $16.357B | 24.08 |
| CochLear (CHEOY) | Australia | $14.085B | 0.00 |
| Revvity (RVTY) | United States | $13.482B | 23.65 |
| Natera (NTRA) | United States | $13.082B | 0.00 |
| Viatris (VTRS) | United States | $12.621B | 3.77 |
| Medpace Holdings (MEDP) | United States | $11.970B | 39.38 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.469B | 0.00 |
| Charles River Laboratories (CRL) | United States | $10.737B | 20.56 |
| Solventum (SOLV) | United States | $10.249B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $7.864B | 0.00 |
| HealthEquity (HQY) | United States | $7.107B | 52.36 |
| Organon (OGN) | United States | $5.485B | 5.20 |
| Bausch + Lomb (BLCO) | Canada | $5.392B | 21.61 |
| Doximity (DOCS) | United States | $5.173B | 36.01 |
| PACS (PACS) | United States | $4.565B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.508B | 32.09 |
| Life Times (LTH) | United States | $3.336B | 34.96 |
| Sotera Health (SHC) | United States | $3.165B | 15.53 |
| GoodRx Holdings (GDRX) | United States | $2.953B | 112.43 |
| Agilon Health (AGL) | United States | $2.591B | 0.00 |
| Progyny (PGNY) | United States | $2.566B | 44.18 |
| NovoCure (NVCR) | Jersey | $2.369B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.126B | 8.42 |
| Premier (PINC) | United States | $1.983B | 8.48 |
| BrightSpring Health Services (BTSG) | United States | $1.927B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.906B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.566B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $1.507B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.437B | 0.00 | |
| Embecta (EMBC) | United States | $0.713B | 4.85 |
| CareDx (CDNA) | United States | $0.678B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.650B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.615B | 6.53 |
| InnovAge Holding (INNV) | United States | $0.604B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.583B | 15.27 |
| GeneDx Holdings (WGS) | United States | $0.512B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.505B | 0.00 |
| Enhabit (EHAB) | United States | $0.461B | 45.95 |
| ModivCare (MODV) | United States | $0.388B | 7.27 |
| Sonida Senior Living (SNDA) | United States | $0.383B | 0.00 |
| LifeMD (LFMD) | United States | $0.349B | 0.00 |
| MultiPlan (MPLN) | United States | $0.346B | 0.00 |
| DocGo (DCGO) | United States | $0.298B | 16.28 |
| Sharecare (SHCR) | United States | $0.295B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.294B | 0.00 |
| Beauty Health (SKIN) | United States | $0.273B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.228B | 0.00 |
| So-Young (SY) | China | $0.105B | 53.00 |
| Pono Capital Two (PTWO) | United States | $0.079B | 0.00 |
| NeueHealth (NEUE) | United States | $0.049B | 6.67 |
| IceCure Medical (ICCM) | Israel | $0.049B | 0.00 |
| Oncology Institute (TOI) | United States | $0.037B | 0.00 |
| Nutex Health (NUTX) | United States | $0.034B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.033B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.028B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.027B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.026B | 0.00 |
| OncoCyte (OCX) | United States | $0.023B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.013B | 0.00 |
| DermTech (DMTK) | United States | $0.011B | 0.00 |
| TRxADE HEALTH (MEDS) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| OpGen (OPGN) | United States | $0.004B | 0.00 |
| Assure Holdings (IONM) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |